In contrast, FGF23 elevation in the presence of low phosphate levels, as is the case in X-linked hypophosphatemia (XLH), does not seem to be associated with the development of cardiac hypertrophy in animal models [27,28] or in patients [29,30]. Here, FGF23 is linked to cardiac hypertrophy.